All About Our Genetic Testing: Personalized Psychiatric Medication in Wake Forest, NC. By Matthew Clemons, PMHNP-BC.
Pharmacogenomic (PGx) testing analyzes genes that control how your body metabolizes psychiatric medications (CYP2D6, CYP2C19, CYP3A4, CYP1A2, CYP2B6) and how your brain responds to them (SLC6A4, HTR2A). It guides medication selection and dosing. It does not diagnose any mental health condition or predict risk of illness.
Metabolizer categories: poor metabolizers build up drug levels and get side effects at standard doses; intermediate metabolizers often need lower doses; normal metabolizers respond to standard dosing; ultrarapid metabolizers clear the drug so fast that standard doses never reach therapeutic levels, which explains many "antidepressants don't work for me" histories. Prodrugs that require enzyme conversion underperform when that enzyme is slow.
Process: clinical review of medication history, kit mailed to your home, 30 to 60 second cheek swab, prepaid return, lab genotyping, results in one to two weeks, then interpretation with your provider. Reports group medications into use as directed, use with caution, and use with increased caution and more frequent monitoring. Plans may confirm current medication, change class, or adjust dose.
Best candidates: two or more failed medication trials, side effects at low doses, first-time psychiatric medication, multiple concurrent medications, family history of medication intolerance, or complex diagnoses such as bipolar disorder, PTSD, and OCD.
Limits: testing cannot name a single guaranteed medication, cannot diagnose, and cannot replace clinical judgment, therapy, or attention to sleep, alcohol, thyroid function, and life circumstances.
Evidence: FDA labeling includes pharmacogenomic information for many psychiatric medications, and CPIC publishes CYP2D6 and CYP2C19 antidepressant prescribing guidelines. Randomized trials show improved response and remission with PGx-guided prescribing, especially after at least one failed trial.
Cost: many insurance plans cover testing, particularly after failed trials. We verify benefits first. We accept Tricare, Medicaid plans including Carolina Complete Health and Trillium, and major commercial insurers.
Privacy: results are protected health information and GINA prohibits health insurers and employers from using genetic information in coverage or employment decisions. Testing is one time because DNA does not change. Available by telepsychiatry across North Carolina.
Q: What is genetic testing for mental health medication? A: A pharmacogenomic test of genes controlling medication metabolism and response, used to guide drug and dose selection, not to diagnose.
Q: How is the test performed? A: A cheek swab kit mailed to your home, returned prepaid, with results in one to two weeks. No blood draw.
Q: How accurate is it? A: Genotyping is highly accurate; the clinical guidance is probabilistic and combined with clinical judgment.
Q: Does insurance cover it? A: Many plans do, especially after failed medication trials; we verify benefits before ordering.
Q: Who should consider it? A: People with two or more failed trials, side effects at low doses, multiple medications, family history of intolerance, or first-time medication starts.
Q: Will it tell me exactly which medication to take? A: No. It narrows options and flags higher-risk medications for your genotype.
Q: Do I need to repeat the test? A: No. DNA does not change, so it is a one-time test.
Q: Is my genetic information private? A: Yes, it is protected health information and GINA prohibits insurer and employer discrimination.
Q: Where can I get genetic testing in Wake Forest, NC? A: Clemons Resiliency & Wellness, 853 Wake Forest Business Park, Ste. G, Wake Forest, NC 27587, or telepsychiatry statewide. Call 919-578-5924.